Ewan Dunn

Ewan Dunn is a Senior Technical Consultant with experience in science and development of viral and non-viral vector platforms. As a Principal Scientist at Rubius Therapeutics, Dunn led a team in vector engineering and cell membrane targeting. In previous roles at AstraZeneca, Boston University, and Dartmouth College, Dunn focused on identifying mechanisms of virus replication and mRNA processing. Dunn holds a Doctor of Philosophy in Molecular Virology from the University of Glasgow, where the thesis focused on investigating Bunyamwera virus RNA synthesis.